来源:医咖2026年开年,全球医疗器械巨头美敦力在华业务率先抛出关键动作,引发行业广泛关注。为配合“一个外科”(One Surgical)战略的深化落地,美敦力外科中国业务线启动重大人事调整,这既是其近年来持续优化外科板块组织效能的重要举措,也彰显了这家医械龙头深耕中国市场、强化外科业务竞争力的坚定决心。此次人事变动的核心节点,是美敦力中国区业务高级总监张本炎的离任。据悉,张本炎已于上周正式加入...
Source Link来源:医咖2026年开年,全球医疗器械巨头美敦力在华业务率先抛出关键动作,引发行业广泛关注。为配合“一个外科”(One Surgical)战略的深化落地,美敦力外科中国业务线启动重大人事调整,这既是其近年来持续优化外科板块组织效能的重要举措,也彰显了这家医械龙头深耕中国市场、强化外科业务竞争力的坚定决心。此次人事变动的核心节点,是美敦力中国区业务高级总监张本炎的离任。据悉,张本炎已于上周正式加入...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.